What is Zacks Research’s Forecast for PDCO FY2025 Earnings?

Patterson Companies, Inc. (NASDAQ:PDCO) – Research analysts at Zacks Research dropped their FY2025 earnings estimates for shares of Patterson Companies in a research report issued on Wednesday, March 19th. Zacks Research analyst I. Bandyopadhyay now anticipates that the company will post earnings of $2.25 per share for the year, down from their prior estimate of $2.26. The consensus estimate for Patterson Companies’ current full-year earnings is $2.25 per share. Zacks Research also issued estimates for Patterson Companies’ Q1 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.91 EPS, FY2026 earnings at $2.33 EPS, Q1 2027 earnings at $0.28 EPS and Q2 2027 earnings at $0.46 EPS.

Several other analysts have also issued reports on PDCO. Morgan Stanley upped their target price on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Stifel Nicolaus cut their price target on shares of Patterson Companies from $25.00 to $24.00 and set a “hold” rating for the company in a research note on Thursday, December 5th. StockNews.com started coverage on shares of Patterson Companies in a report on Wednesday. They issued a “hold” rating for the company. Robert W. Baird upped their price target on shares of Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a report on Thursday, December 12th. Finally, Leerink Partnrs downgraded shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Eleven analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.57.

Patterson Companies Stock Performance

NASDAQ:PDCO opened at $31.19 on Friday. The company has a fifty day moving average of $31.03 and a 200-day moving average of $26.11. The firm has a market capitalization of $2.76 billion, a P/E ratio of 18.24, a P/E/G ratio of 2.71 and a beta of 0.99. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. Patterson Companies has a twelve month low of $19.45 and a twelve month high of $31.79.

Institutional Trading of Patterson Companies

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Harbour Investments Inc. acquired a new stake in shares of Patterson Companies in the fourth quarter worth approximately $26,000. Huntington National Bank raised its holdings in shares of Patterson Companies by 54.0% in the 4th quarter. Huntington National Bank now owns 1,115 shares of the company’s stock valued at $34,000 after buying an additional 391 shares during the period. GAMMA Investing LLC raised its holdings in shares of Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock valued at $41,000 after buying an additional 680 shares during the period. Anchor Investment Management LLC boosted its position in shares of Patterson Companies by 20.5% during the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock worth $51,000 after acquiring an additional 400 shares in the last quarter. Finally, Quadrant Capital Group LLC boosted its position in shares of Patterson Companies by 501.6% during the 4th quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company’s stock worth $58,000 after acquiring an additional 1,570 shares in the last quarter. 85.43% of the stock is owned by institutional investors and hedge funds.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.